0001179110-19-012057.txt : 20191126
0001179110-19-012057.hdr.sgml : 20191126
20191126075151
ACCESSION NUMBER: 0001179110-19-012057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190125
FILED AS OF DATE: 20191126
DATE AS OF CHANGE: 20191126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fruchtman Steven M
CENTRAL INDEX KEY: 0001631251
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36020
FILM NUMBER: 191247587
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Onconova Therapeutics, Inc.
CENTRAL INDEX KEY: 0001130598
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
BUSINESS PHONE: 267-759-3681
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20090526
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC
DATE OF NAME CHANGE: 20001226
4
1
edgar.xml
FORM 4 -
X0306
4
2019-01-25
0
0001130598
Onconova Therapeutics, Inc.
ONTX
0001631251
Fruchtman Steven M
375 PHEASANT RUN
NEWTOWN
PA
18940
1
1
0
0
President, Chief Executive Off
Common Stock
2019-11-25
4
P
0
149000
.2
A
149426
D
Warrant (right to purchase)
.2
2019-11-25
4
P
0
149000
A
2019-11-25
2024-11-25
Common Stock
149000
149000
D
The common stock and warrants were acquired in a public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. The public offering price for each unit was $0.20.
/s/ Mark Guerin as attorney-in-fact
2019-11-25